Delivery Order SPE2D018D0005-SPE2D324F9992

Award Date 5/21/24
Potential Completion Date 5/24/24
Potential Value $1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D324F9992
    Delivery Order

This federal contract award with ID SPE2D018D0005|SPE2D324F9992 was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The $1,037.23 firm fixed price delivery order is for 4,564,682,954 units of Reagent Anti-D Bioclone, a monoclonal diagnostic reagent. The contract has an ultimate completion date of May 24, 2024.

Ortho-Clinical Diagnostics, Inc. has provided medical equipment, reagents, consumables, and testing services to several federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. They hold various indefinite-delivery/indefinite-quantity (IDIQ) contracts and blanket purchase agreements to supply critical laboratory equipment, reagents, and blood bank services in support of federal healthcare programs. This specific award does not utilize a small business set-aside.

Generated 8/20/24, 9:13 AM